Defunct Company
Total Trials
4
As Lead Sponsor
1
As Collaborator
3
Total Enrollment
788
NCT00199979
Zidovudine / Lamivudine + Nevirapine Twice Daily, Versus Tenofovir + Lamivudine + Nevirapine Once Daily in ARV-Naive Patients
Phase: Phase 3
Role: Lead Sponsor
Start: Apr 30, 2005
Completion: Jun 30, 2008
NCT01072682
Safety Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Renal Failure
Phase: N/A
Role: Collaborator
Start: Feb 28, 2010
Completion: May 31, 2011
NCT04649775
AirFLO2 Treatment for Hypoxia and/or Tachypnea in Patients With COVID-19
Start: Apr 9, 2021
Completion: Nov 8, 2021
NCT06624787
Development Of A Rapid Diagnostic Test To Identify Crimean-Congo Haemorrhagic Fever At The Point-Of-Care
Start: Apr 30, 2026
Completion: Sep 30, 2027